Related Concepts
Related Feeds
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
Related Papers
Clinical Lymphoma, Myeloma & Leukemia
Maro OhanianNaveen Pemmaraju
Journal of Pediatric Ophthalmology and Strabismus
Murat SökerSevda Ipek Söker
The Journal of the Association of Physicians of India
P S GhalautO Jeewan
La Tunisie médicale
Lilia Ben HassineIbtissem Bellagha
Gynécologie, obstétrique & fertilité
M Adnène LaatiriA Khlif